Activated B cells express functional Fas ligand
Michael Hahne
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorToufic Renno
Ludwig Institute for Cancer Research, University of Lausanne, BIL Research Centre, CH-1066 Epalinges, Switzerland
Search for more papers by this authorMichael Schroeter
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorMartin Irmler
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorLars French
Dermatology and Epithelium Network, University of Geneva, Medical School, Geneva, Switzerland
Search for more papers by this authorThierry Bornand
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorH. Robson MacDonald
Ludwig Institute for Cancer Research, University of Lausanne, BIL Research Centre, CH-1066 Epalinges, Switzerland
Search for more papers by this authorCorresponding Author
Jürg Tschopp
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Institute of Biochemistry, University of Lausanne, Ch. des Boveresses 155, CH-1066 Epalinges, Switzerland (Fax: +41-21-692-5705)Search for more papers by this authorMichael Hahne
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorToufic Renno
Ludwig Institute for Cancer Research, University of Lausanne, BIL Research Centre, CH-1066 Epalinges, Switzerland
Search for more papers by this authorMichael Schroeter
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorMartin Irmler
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorLars French
Dermatology and Epithelium Network, University of Geneva, Medical School, Geneva, Switzerland
Search for more papers by this authorThierry Bornand
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Search for more papers by this authorH. Robson MacDonald
Ludwig Institute for Cancer Research, University of Lausanne, BIL Research Centre, CH-1066 Epalinges, Switzerland
Search for more papers by this authorCorresponding Author
Jürg Tschopp
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Institute of Biochemistry, University of Lausanne, Ch. des Boveresses 155, CH-1066 Epalinges, Switzerland (Fax: +41-21-692-5705)Search for more papers by this authorAbstract
Fas ligand (FasL, Apo-1L) is a member of the tumor necrosis factor protein family and binding to its receptor (Fas, Apo-1, CD95) triggers cell death through apoptosis. Ligand expression is restricted to cells with known cytolytic activity and found on hematopoietic cells of the T cell and natural killer lineage. Here we provide evidence that B lymphocytes can express FasL. Flow cytometric analysis revealed that FasL is expressed on the surface of B cells upon stimulation with either lipopolysaccharide or phorbol 12-myristute 13-acetate/ionomycin. FasL expression on activated B cells was confirmed by Western blot and reverse transcriptase polymerase chain reaction analysis. FasL on B cells is functional since lipopolysaccharide-activated B lymphocytes derived from wild type, but not from g/d mutant mice, were able to kill Fas-sensitive target cells. Our data suggest that the Fas system may contribute to the control of B cell homeostasis.
References
- 1 Smith, C. A., Farrah, T. and Goodwin, R. C., Cell 1994. 76: 959.
- 2 Suda, T., Takahashi, T., Golstein, P. and Nagata, S., Cell 1993. 75: 1169.
- 3 Nagata, S. and Golstein, P., Science 1995. 267: 1449.
- 4 Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J. and Debatin, K. M., Curr. Opin. Immunol. 1994. 6: 279.
- 5 Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M. and Krammer, P. H., Science 1989. 245: 301.
- 6 Yonehara, S., Ishii, A. and Yonehara, M., J. Exp. Med. 1989. 169: 1747.
- 7 Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S., Cell 1991. 66: 233.
- 8 Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J., Nature 1994. 370: 650.
- 9 Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H. and Golstein, P., Science 1994. 265: 528.
- 10 Kojima, H., Shinohara, N., Hanoaka, S., Someya-Shirota, Y., Takagaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K., Shinkai, Y., Alt, F. W., Masutzawa, A., Yonehara, S. and Takayama, H., Immunity 1994. 1: 357.
- 11 Alderson, M. R., Tough, T. W., Davissmith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H., J. Exp. Med. 1995. 181: 71.
- 12 Brunner, T., Mogil, R. J., Laface, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R., Nature 1995. 373: 441.
- 13 Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H., Nature 1995. 373: 438.
- 14 Ju, S. T., Panka, D. J., Cui, H. L., Ettinger, R., Elkhatib, M., Sherr, D. H., Stanger, B. Z. and Marshakrothstein, A., Nature 1995. 373: 444.
- 15 Nagata, S., Semin. Immunol. 1994. 6: 3.
- 16 Nagata, S. and Suda, T., Immunol. Today 1995. 16: 39.
- 17 Rouvier, E., Luciani, M. F. and Golstein, P., J. Exp. Med. 1993. 177: 195.
- 18 Arase, H., Arase, N., Kobashi, Y. N., Yonehara, S. and Onoe, K., J. Exp. Med. 1994. 180: 423.
- 19 Arase, H., Arase, N. and Saito, T., J. Exp. Med. 1995. 181: 1235.
- 20 Hahne, M., Peitsch, M. C., Irmler, M., Schroter, M., Lowin, B., Rousseau, M., Bron, C., Renno, T., French, L. and Tschopp, J., Int. Immunol. 1995. 7: 1381.
- 21 Dialynas, D. P., Loken, M. R., Glasebrook, A. L. and Fitch, F. W., J. Exp. Med. 1981. 153: 595.
- 22 Tokunage, K., Taniguchi, H., Yoda, K., Shimizu, M. and Sakiyama, S., Nucleic Acids Res. 1986. 14: 2829.
- 23 Laemmli, U. K., Nature 1970. 227: 680.
- 24 Suda, T. and Nagata, S., J. Exp. Med. 1994. 179: 873.
- 25 Vignaux, F., Vivier, E., Malissen, B., Depraetere, V., Nagata, S. and Golstein, P., J. Exp. Med. 1995. 181: 781.
- 26 Drappa, J., Brot, N. and Elkon, K. B., Proc. Natl. Acad. Sci. USA 1993. 90: 10340.
- 27 Miyawaki, T., Uehara, T., Nibu, R., Tsuhi, T., Yachie, A., Yonehara, S. and Taniguchi, N., J. Immunol. 1992. 149: 3753.
- 28 Klas, C., Debatin, K. M., Jonker, R. R. and Krammer, P. H., Int. Immunol. 1993. 5: 625.
- 29 Owen, S. L. B., Radinsky, R., Kruzel, E., Berry, K. and Yonehara, S., Cancer Res. 1994. 54: 1580.
- 30 Moller, P., Henne, C., Leithauser, F., Eichelmann, A., Schmidt, A., Bruderlein, S., Dhein, J. and Krammer, P. H., Blood 1993. 81: 2067.
- 31 Mariani, S., Matiba, B., Baeumler, C. and Krammer, P. H., Eur. J. Immunol. 1995. 25: 2303.
- 32 Springer, T. A., Nature 1990. 346: 425.
- 33 Rathmell, J. C., Cooke, M. P., Ho, W. Y., Grein, J., Townsend, S. E., Davis, M. M. and Goodnow, C. C., Nature 1995. 376: 181.
- 34 Darzynkiewcz, Z., Bruno, S., Del Bino, G., Gorzyca, W., Lassota, P. and Traganow, F., Cytometry 1992. 13: 795.
- 35 Renno, T., Hahne, M., Tschopp, J. and Macdonald, H. R., J. Exp. Med. 1996, in press.
- 36 Stalder, T., Hahn, S. and Erb, P., J. Immunol. 1994. 152: 1127.